3690 GENES FOUNDi
Show / hide columns XML | RDF | TSV | Page of 74 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x Prognostic p-valuei x RNA tissue categoryi x
A1BGAlpha-1-B glycoproteinPlasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Liver cancer: 3.97e-4
Tissue enriched
A2MAlpha-2-macroglobulinCancer-related genes
Candidate cardiovascular disease genes
Plasma proteins
Predicted secreted proteins
Expressed in all
A2ML1Alpha-2-macroglobulin like 1Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
A4GNTAlpha-1,4-N-acetylglucosaminyltransferasePredicted secreted proteins
Tissue enriched
AADACArylacetamide deacetylaseEnzymes
Predicted intracellular proteins
Ovarian cancer: 5.58e-6
Stomach cancer: 2.19e-4
Pancreatic cancer: 5.02e-4
Group enriched
AADACL2Arylacetamide deacetylase like 2Predicted secreted proteins
Tissue enriched
AAMPAngio associated migratory cell proteinPlasma proteins
Predicted intracellular proteins
Microtubules
Cytosol
Liver cancer: 4.94e-7
Endometrial cancer: 1.62e-4
Expressed in all
AANATAralkylamine N-acetyltransferaseEnzymes
Predicted intracellular proteins
Predicted secreted proteins
CytosolTissue enhanced
AATKApoptosis associated tyrosine kinaseEnzymes
Predicted intracellular proteins
Predicted membrane proteins
MitochondriaTissue enhanced
ABC13-47488600E17.1Predicted intracellular proteins
Tissue enhanced
ABCG1ATP binding cassette subfamily G member 1Predicted membrane proteins
Predicted secreted proteins
Transporters
Golgi apparatus
Vesicles
Renal cancer: 7.16e-6
Expressed in all
ABHD10Abhydrolase domain containing 10Enzymes
Predicted secreted proteins
MitochondriaRenal cancer: 4.72e-9
Cervical cancer: 7.57e-4
Expressed in all
ABHD14AAbhydrolase domain containing 14APredicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
VesiclesLung cancer: 4.72e-4
Expressed in all
ABHD14A-ACY1ABHD14A-ACY1 readthroughPredicted intracellular proteins
Predicted secreted proteins
VesiclesTissue enhanced
ABHD15Abhydrolase domain containing 15Predicted secreted proteins
Nucleoplasm
Cytosol
Mixed
ABHD8Abhydrolase domain containing 8Predicted intracellular proteins
Nucleoplasm
Nuclear bodies
Pancreatic cancer: 3.04e-5
Colorectal cancer: 5.25e-4
Mixed
ABI3BPABI family member 3 binding proteinPlasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Renal cancer: 6.14e-4
Mixed
ABL2ABL proto-oncogene 2, non-receptor tyrosine kinaseCancer-related genes
Enzymes
Predicted intracellular proteins
RAS pathway related proteins
NucleoplasmRenal cancer: 1.78e-7
Cervical cancer: 3.50e-4
Urothelial cancer: 8.40e-4
Mixed
AC006116.20Predicted secreted proteins
Tissue enriched
AC010731.4Predicted intracellular proteins
Not detected
AC011513.3Predicted secreted proteins
Group enriched
AC114783.1Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
AC136352.2Predicted secreted proteins
Not detected
AC145212.2MaFF-interacting protein Predicted secreted proteins
Mixed
AC233755.1Predicted secreted proteins
Tissue enhanced
ACACBAcetyl-CoA carboxylase betaEnzymes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Renal cancer: 1.15e-5
Pancreatic cancer: 1.93e-4
Tissue enriched
ACANAggrecanPredicted intracellular proteins
Predicted secreted proteins
Renal cancer: 1.47e-6
Tissue enhanced
ACEAngiotensin I converting enzymeCandidate cardiovascular disease genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
VesiclesTissue enhanced
ACHEAcetylcholinesterase (Cartwright blood group)Blood group antigen proteins
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Golgi apparatus
Vesicles
Renal cancer: 3.88e-5
Glioma: 7.16e-4
Tissue enhanced
ACP1Acid phosphatase 1, solubleEnzymes
Plasma proteins
Predicted intracellular proteins
Nucleus
Cytosol
Liver cancer: 6.67e-6
Melanoma: 3.04e-4
Expressed in all
ACP2Acid phosphatase 2, lysosomalDisease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
Predicted secreted proteins
Endometrial cancer: 1.04e-4
Expressed in all
ACP5Acid phosphatase 5, tartrate resistantDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins
CytosolTissue enhanced
ACP6Acid phosphatase 6, lysophosphatidicEnzymes
Predicted intracellular proteins
Predicted secreted proteins
Urothelial cancer: 6.44e-4
Expressed in all
ACP7Acid phosphatase 7, tartrate resistant (putative)Enzymes
Predicted intracellular proteins
Predicted secreted proteins
Group enriched
ACPPAcid phosphatase, prostateCancer-related genes
Enzymes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
ACRAcrosinEnzymes
Predicted secreted proteins
Tissue enriched
ACRBPAcrosin binding proteinPredicted secreted proteins
Nucleoplasm
Vesicles
Tissue enriched
ACRV1Acrosomal vesicle protein 1Predicted secreted proteins
Tissue enriched
ACSF2Acyl-CoA synthetase family member 2Predicted membrane proteins
Predicted secreted proteins
Nucleoplasm
Microtubules
Cytosol
Renal cancer: 2.17e-4
Urothelial cancer: 2.41e-4
Tissue enhanced
ACSF3Acyl-CoA synthetase family member 3Disease related genes
Predicted intracellular proteins
Predicted membrane proteins
Renal cancer: 5.97e-6
Pancreatic cancer: 3.76e-5
Expressed in all
ACTN1Actinin alpha 1Disease related genes
Plasma proteins
Predicted intracellular proteins
Plasma membrane
Focal adhesion sites
Renal cancer: 9.08e-10
Lung cancer: 7.63e-5
Head and neck cancer: 2.49e-4
Urothelial cancer: 8.00e-4
Expressed in all
ACVR1Activin A receptor type 1Cancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Nucleoli
Cytosol
Urothelial cancer: 5.17e-4
Expressed in all
ACVR1CActivin A receptor type 1CEnzymes
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
ACVRL1Activin A receptor like type 1Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
ACYP1Acylphosphatase 1Enzymes
Predicted intracellular proteins
Predicted secreted proteins
Nucleus
Cytosol
Liver cancer: 6.14e-7
Breast cancer: 1.17e-4
Expressed in all
ACYP2Acylphosphatase 2Enzymes
Predicted intracellular proteins
Predicted secreted proteins
NucleoplasmExpressed in all
ADAM10ADAM metallopeptidase domain 10Cancer-related genes
CD markers
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Vesicles
Plasma membrane
Lung cancer: 8.46e-5
Pancreatic cancer: 1.90e-4
Expressed in all
ADAM12ADAM metallopeptidase domain 12Predicted membrane proteins
Predicted secreted proteins
Transporters
Plasma membraneRenal cancer: 2.39e-14
Tissue enriched
ADAM15ADAM metallopeptidase domain 15Predicted membrane proteins
Predicted secreted proteins
VesiclesRenal cancer: 5.64e-9
Glioma: 3.49e-5
Liver cancer: 3.49e-4
Expressed in all
ADAM17ADAM metallopeptidase domain 17CD markers
Disease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
CytosolUrothelial cancer: 4.23e-5
Expressed in all
Page of 74 | next »